Overexpression of TRIM3 protects against LPS-induced acute kidney injury via repressing IRF3 pathway and NLRP3 inflammasome

Purpose The pathological process of sepsis involves multiple system organs, including kidney. Sepsis-induced acute kidney injury (AKI) has high morbidity and high mortality. Overproduced inflammatory factors contribute to the occurrence and evolvement of AKI. Here, the role and underlying mechanism...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International urology and nephrology 2022-06, Vol.54 (6), p.1331-1342
Hauptverfasser: Li, Weiwei, Tan, Yunzhi, Gao, Feng, Xiang, Miaomiao
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1342
container_issue 6
container_start_page 1331
container_title International urology and nephrology
container_volume 54
creator Li, Weiwei
Tan, Yunzhi
Gao, Feng
Xiang, Miaomiao
description Purpose The pathological process of sepsis involves multiple system organs, including kidney. Sepsis-induced acute kidney injury (AKI) has high morbidity and high mortality. Overproduced inflammatory factors contribute to the occurrence and evolvement of AKI. Here, the role and underlying mechanism of tripartite motif containing 3 (TRIM3) and in AKI was explored. Methods Lipopolysaccharide (LPS) was used for constructing AKI model both in vitro and in vivo . RT-PCR and western blot were performed to detect TRIM3, Interferon regulatory factor 3 (IRF3) and NLRP3-ASC-Caspase1 inflammasome. Upon selectively regulating the TRIM3 or IRF3 expression, the proliferation, apoptosis and inflammatory response were detected. The interaction between TRIM3 and IRF3 was verified by Immunoprecipitation (IP). Results TRIM3 was down-regulated in mediated injury renal tubular epithelial cell line HK-2 treated with LPS. Overexpression of TRIM3 promoted cell viability and reduced apoptosis. In addition, overexpression of TRIM3 inhibited the expression of inflammatory factors (IL-1β, IL-6, TNF-α and IL-18), dampened the phosphorylation of IRF3 and repressed NLRP3 inflammasome activation. Furthermore, TRIM3 overexpression significantly eased the LPS-induced damage on AKI rat model and decreased the serum creatinine and urea nitrogen levels in rat kidney tissues. The results of immunohistochemistry (IHC) and Western blot manifested that TRIM3 was increased dramatically after TRIM3 was overexpressed in the rat kidney tissues, while IRF3 and NLRP3-ASC-Caspase1 inflammasome were significantly repressed following TRIM3 upregulation in the kidney tissues. Mechanistically, TRIM3 interacted with IRF3 and inhibited its phosphorylation. Conclusion Overexpression of TRIM3 protected against LPS-induced AKI by inhibiting the IRF3 pathway and NLRP3 inflammasome activation.
doi_str_mv 10.1007/s11255-021-03017-z
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2581815096</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2581815096</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-c84c7bcafd7cc858cd1f8c06949473a81b3301047f11033128f1ed42bf2111923</originalsourceid><addsrcrecordid>eNp9kU1v1DAQhi0EoqXwBzggS1y4BDy2E9tHVFG60kKrpZwtrzNesmycxU5Kt_x5DCkf4sDJlvzM65l5CHkK7CUwpl5lAF7XFeNQMcFAVbf3yDHUSlS81vL-X_cj8ijnLWPMaMYekiMhGyl0bY7Jt4trTHizT5hzN0Q6BHq1WrwTdJ-GEf2Yqdu4LuaRLi8_VF1sJ48tdX4akX7u2ogH2sXtlA70unM04RwUN3SxOishbvz01R2oiy19v1xdigKHnet7l4ceH5MHwe0yPrk7T8jHszdXp-fV8uLt4vT1svJC1WPltfRq7V1olfe61r6FoD1rjDRSCadhLcr0TKoAwIQArgNgK_k6cAAwXJyQF3NumenLhHm0fZc97nYu4jBlWzYEGmpmmoI-_wfdDlOKpTvLmwa4ksaYQvGZ8mnIOWGw-9T1Lh0sMPtDjZ3V2KLG_lRjb0vRs7voad1j-7vkl4sCiBnI5SluMP35-z-x3wHJ8ZlU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2661274999</pqid></control><display><type>article</type><title>Overexpression of TRIM3 protects against LPS-induced acute kidney injury via repressing IRF3 pathway and NLRP3 inflammasome</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Li, Weiwei ; Tan, Yunzhi ; Gao, Feng ; Xiang, Miaomiao</creator><creatorcontrib>Li, Weiwei ; Tan, Yunzhi ; Gao, Feng ; Xiang, Miaomiao</creatorcontrib><description>Purpose The pathological process of sepsis involves multiple system organs, including kidney. Sepsis-induced acute kidney injury (AKI) has high morbidity and high mortality. Overproduced inflammatory factors contribute to the occurrence and evolvement of AKI. Here, the role and underlying mechanism of tripartite motif containing 3 (TRIM3) and in AKI was explored. Methods Lipopolysaccharide (LPS) was used for constructing AKI model both in vitro and in vivo . RT-PCR and western blot were performed to detect TRIM3, Interferon regulatory factor 3 (IRF3) and NLRP3-ASC-Caspase1 inflammasome. Upon selectively regulating the TRIM3 or IRF3 expression, the proliferation, apoptosis and inflammatory response were detected. The interaction between TRIM3 and IRF3 was verified by Immunoprecipitation (IP). Results TRIM3 was down-regulated in mediated injury renal tubular epithelial cell line HK-2 treated with LPS. Overexpression of TRIM3 promoted cell viability and reduced apoptosis. In addition, overexpression of TRIM3 inhibited the expression of inflammatory factors (IL-1β, IL-6, TNF-α and IL-18), dampened the phosphorylation of IRF3 and repressed NLRP3 inflammasome activation. Furthermore, TRIM3 overexpression significantly eased the LPS-induced damage on AKI rat model and decreased the serum creatinine and urea nitrogen levels in rat kidney tissues. The results of immunohistochemistry (IHC) and Western blot manifested that TRIM3 was increased dramatically after TRIM3 was overexpressed in the rat kidney tissues, while IRF3 and NLRP3-ASC-Caspase1 inflammasome were significantly repressed following TRIM3 upregulation in the kidney tissues. Mechanistically, TRIM3 interacted with IRF3 and inhibited its phosphorylation. Conclusion Overexpression of TRIM3 protected against LPS-induced AKI by inhibiting the IRF3 pathway and NLRP3 inflammasome activation.</description><identifier>ISSN: 1573-2584</identifier><identifier>ISSN: 0301-1623</identifier><identifier>EISSN: 1573-2584</identifier><identifier>DOI: 10.1007/s11255-021-03017-z</identifier><identifier>PMID: 34643859</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Acute Kidney Injury - pathology ; Animals ; Apoptosis ; Carrier Proteins - adverse effects ; Carrier Proteins - genetics ; Carrier Proteins - metabolism ; Cell viability ; Creatinine ; Epithelial cells ; Female ; Humans ; IL-1β ; Immunohistochemistry ; Immunoprecipitation ; Inflammasomes ; Inflammasomes - metabolism ; Inflammation ; Interferon ; Interferon regulatory factor ; Interferon regulatory factor 3 ; Interferon Regulatory Factor-3 - genetics ; Interferon Regulatory Factor-3 - metabolism ; Interleukin 18 ; Interleukin 6 ; Kidneys ; Lipopolysaccharides ; Lipopolysaccharides - pharmacology ; Male ; Medicine ; Medicine &amp; Public Health ; Morbidity ; Nephrology ; Nephrology - Original Paper ; NLR Family, Pyrin Domain-Containing 3 Protein - genetics ; NLR Family, Pyrin Domain-Containing 3 Protein - metabolism ; Phosphorylation ; Rats ; Sepsis ; Tumor necrosis factor-α ; Urology</subject><ispartof>International urology and nephrology, 2022-06, Vol.54 (6), p.1331-1342</ispartof><rights>The Author(s), under exclusive licence to Springer Nature B.V. 2021</rights><rights>2021. The Author(s), under exclusive licence to Springer Nature B.V.</rights><rights>The Author(s), under exclusive licence to Springer Nature B.V. 2021.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-c84c7bcafd7cc858cd1f8c06949473a81b3301047f11033128f1ed42bf2111923</citedby><cites>FETCH-LOGICAL-c375t-c84c7bcafd7cc858cd1f8c06949473a81b3301047f11033128f1ed42bf2111923</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11255-021-03017-z$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11255-021-03017-z$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34643859$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Weiwei</creatorcontrib><creatorcontrib>Tan, Yunzhi</creatorcontrib><creatorcontrib>Gao, Feng</creatorcontrib><creatorcontrib>Xiang, Miaomiao</creatorcontrib><title>Overexpression of TRIM3 protects against LPS-induced acute kidney injury via repressing IRF3 pathway and NLRP3 inflammasome</title><title>International urology and nephrology</title><addtitle>Int Urol Nephrol</addtitle><addtitle>Int Urol Nephrol</addtitle><description>Purpose The pathological process of sepsis involves multiple system organs, including kidney. Sepsis-induced acute kidney injury (AKI) has high morbidity and high mortality. Overproduced inflammatory factors contribute to the occurrence and evolvement of AKI. Here, the role and underlying mechanism of tripartite motif containing 3 (TRIM3) and in AKI was explored. Methods Lipopolysaccharide (LPS) was used for constructing AKI model both in vitro and in vivo . RT-PCR and western blot were performed to detect TRIM3, Interferon regulatory factor 3 (IRF3) and NLRP3-ASC-Caspase1 inflammasome. Upon selectively regulating the TRIM3 or IRF3 expression, the proliferation, apoptosis and inflammatory response were detected. The interaction between TRIM3 and IRF3 was verified by Immunoprecipitation (IP). Results TRIM3 was down-regulated in mediated injury renal tubular epithelial cell line HK-2 treated with LPS. Overexpression of TRIM3 promoted cell viability and reduced apoptosis. In addition, overexpression of TRIM3 inhibited the expression of inflammatory factors (IL-1β, IL-6, TNF-α and IL-18), dampened the phosphorylation of IRF3 and repressed NLRP3 inflammasome activation. Furthermore, TRIM3 overexpression significantly eased the LPS-induced damage on AKI rat model and decreased the serum creatinine and urea nitrogen levels in rat kidney tissues. The results of immunohistochemistry (IHC) and Western blot manifested that TRIM3 was increased dramatically after TRIM3 was overexpressed in the rat kidney tissues, while IRF3 and NLRP3-ASC-Caspase1 inflammasome were significantly repressed following TRIM3 upregulation in the kidney tissues. Mechanistically, TRIM3 interacted with IRF3 and inhibited its phosphorylation. Conclusion Overexpression of TRIM3 protected against LPS-induced AKI by inhibiting the IRF3 pathway and NLRP3 inflammasome activation.</description><subject>Acute Kidney Injury - pathology</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>Carrier Proteins - adverse effects</subject><subject>Carrier Proteins - genetics</subject><subject>Carrier Proteins - metabolism</subject><subject>Cell viability</subject><subject>Creatinine</subject><subject>Epithelial cells</subject><subject>Female</subject><subject>Humans</subject><subject>IL-1β</subject><subject>Immunohistochemistry</subject><subject>Immunoprecipitation</subject><subject>Inflammasomes</subject><subject>Inflammasomes - metabolism</subject><subject>Inflammation</subject><subject>Interferon</subject><subject>Interferon regulatory factor</subject><subject>Interferon regulatory factor 3</subject><subject>Interferon Regulatory Factor-3 - genetics</subject><subject>Interferon Regulatory Factor-3 - metabolism</subject><subject>Interleukin 18</subject><subject>Interleukin 6</subject><subject>Kidneys</subject><subject>Lipopolysaccharides</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Morbidity</subject><subject>Nephrology</subject><subject>Nephrology - Original Paper</subject><subject>NLR Family, Pyrin Domain-Containing 3 Protein - genetics</subject><subject>NLR Family, Pyrin Domain-Containing 3 Protein - metabolism</subject><subject>Phosphorylation</subject><subject>Rats</subject><subject>Sepsis</subject><subject>Tumor necrosis factor-α</subject><subject>Urology</subject><issn>1573-2584</issn><issn>0301-1623</issn><issn>1573-2584</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kU1v1DAQhi0EoqXwBzggS1y4BDy2E9tHVFG60kKrpZwtrzNesmycxU5Kt_x5DCkf4sDJlvzM65l5CHkK7CUwpl5lAF7XFeNQMcFAVbf3yDHUSlS81vL-X_cj8ijnLWPMaMYekiMhGyl0bY7Jt4trTHizT5hzN0Q6BHq1WrwTdJ-GEf2Yqdu4LuaRLi8_VF1sJ48tdX4akX7u2ogH2sXtlA70unM04RwUN3SxOishbvz01R2oiy19v1xdigKHnet7l4ceH5MHwe0yPrk7T8jHszdXp-fV8uLt4vT1svJC1WPltfRq7V1olfe61r6FoD1rjDRSCadhLcr0TKoAwIQArgNgK_k6cAAwXJyQF3NumenLhHm0fZc97nYu4jBlWzYEGmpmmoI-_wfdDlOKpTvLmwa4ksaYQvGZ8mnIOWGw-9T1Lh0sMPtDjZ3V2KLG_lRjb0vRs7voad1j-7vkl4sCiBnI5SluMP35-z-x3wHJ8ZlU</recordid><startdate>20220601</startdate><enddate>20220601</enddate><creator>Li, Weiwei</creator><creator>Tan, Yunzhi</creator><creator>Gao, Feng</creator><creator>Xiang, Miaomiao</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20220601</creationdate><title>Overexpression of TRIM3 protects against LPS-induced acute kidney injury via repressing IRF3 pathway and NLRP3 inflammasome</title><author>Li, Weiwei ; Tan, Yunzhi ; Gao, Feng ; Xiang, Miaomiao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-c84c7bcafd7cc858cd1f8c06949473a81b3301047f11033128f1ed42bf2111923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Acute Kidney Injury - pathology</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>Carrier Proteins - adverse effects</topic><topic>Carrier Proteins - genetics</topic><topic>Carrier Proteins - metabolism</topic><topic>Cell viability</topic><topic>Creatinine</topic><topic>Epithelial cells</topic><topic>Female</topic><topic>Humans</topic><topic>IL-1β</topic><topic>Immunohistochemistry</topic><topic>Immunoprecipitation</topic><topic>Inflammasomes</topic><topic>Inflammasomes - metabolism</topic><topic>Inflammation</topic><topic>Interferon</topic><topic>Interferon regulatory factor</topic><topic>Interferon regulatory factor 3</topic><topic>Interferon Regulatory Factor-3 - genetics</topic><topic>Interferon Regulatory Factor-3 - metabolism</topic><topic>Interleukin 18</topic><topic>Interleukin 6</topic><topic>Kidneys</topic><topic>Lipopolysaccharides</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Morbidity</topic><topic>Nephrology</topic><topic>Nephrology - Original Paper</topic><topic>NLR Family, Pyrin Domain-Containing 3 Protein - genetics</topic><topic>NLR Family, Pyrin Domain-Containing 3 Protein - metabolism</topic><topic>Phosphorylation</topic><topic>Rats</topic><topic>Sepsis</topic><topic>Tumor necrosis factor-α</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Weiwei</creatorcontrib><creatorcontrib>Tan, Yunzhi</creatorcontrib><creatorcontrib>Gao, Feng</creatorcontrib><creatorcontrib>Xiang, Miaomiao</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>International urology and nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Weiwei</au><au>Tan, Yunzhi</au><au>Gao, Feng</au><au>Xiang, Miaomiao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Overexpression of TRIM3 protects against LPS-induced acute kidney injury via repressing IRF3 pathway and NLRP3 inflammasome</atitle><jtitle>International urology and nephrology</jtitle><stitle>Int Urol Nephrol</stitle><addtitle>Int Urol Nephrol</addtitle><date>2022-06-01</date><risdate>2022</risdate><volume>54</volume><issue>6</issue><spage>1331</spage><epage>1342</epage><pages>1331-1342</pages><issn>1573-2584</issn><issn>0301-1623</issn><eissn>1573-2584</eissn><abstract>Purpose The pathological process of sepsis involves multiple system organs, including kidney. Sepsis-induced acute kidney injury (AKI) has high morbidity and high mortality. Overproduced inflammatory factors contribute to the occurrence and evolvement of AKI. Here, the role and underlying mechanism of tripartite motif containing 3 (TRIM3) and in AKI was explored. Methods Lipopolysaccharide (LPS) was used for constructing AKI model both in vitro and in vivo . RT-PCR and western blot were performed to detect TRIM3, Interferon regulatory factor 3 (IRF3) and NLRP3-ASC-Caspase1 inflammasome. Upon selectively regulating the TRIM3 or IRF3 expression, the proliferation, apoptosis and inflammatory response were detected. The interaction between TRIM3 and IRF3 was verified by Immunoprecipitation (IP). Results TRIM3 was down-regulated in mediated injury renal tubular epithelial cell line HK-2 treated with LPS. Overexpression of TRIM3 promoted cell viability and reduced apoptosis. In addition, overexpression of TRIM3 inhibited the expression of inflammatory factors (IL-1β, IL-6, TNF-α and IL-18), dampened the phosphorylation of IRF3 and repressed NLRP3 inflammasome activation. Furthermore, TRIM3 overexpression significantly eased the LPS-induced damage on AKI rat model and decreased the serum creatinine and urea nitrogen levels in rat kidney tissues. The results of immunohistochemistry (IHC) and Western blot manifested that TRIM3 was increased dramatically after TRIM3 was overexpressed in the rat kidney tissues, while IRF3 and NLRP3-ASC-Caspase1 inflammasome were significantly repressed following TRIM3 upregulation in the kidney tissues. Mechanistically, TRIM3 interacted with IRF3 and inhibited its phosphorylation. Conclusion Overexpression of TRIM3 protected against LPS-induced AKI by inhibiting the IRF3 pathway and NLRP3 inflammasome activation.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><pmid>34643859</pmid><doi>10.1007/s11255-021-03017-z</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1573-2584
ispartof International urology and nephrology, 2022-06, Vol.54 (6), p.1331-1342
issn 1573-2584
0301-1623
1573-2584
language eng
recordid cdi_proquest_miscellaneous_2581815096
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Acute Kidney Injury - pathology
Animals
Apoptosis
Carrier Proteins - adverse effects
Carrier Proteins - genetics
Carrier Proteins - metabolism
Cell viability
Creatinine
Epithelial cells
Female
Humans
IL-1β
Immunohistochemistry
Immunoprecipitation
Inflammasomes
Inflammasomes - metabolism
Inflammation
Interferon
Interferon regulatory factor
Interferon regulatory factor 3
Interferon Regulatory Factor-3 - genetics
Interferon Regulatory Factor-3 - metabolism
Interleukin 18
Interleukin 6
Kidneys
Lipopolysaccharides
Lipopolysaccharides - pharmacology
Male
Medicine
Medicine & Public Health
Morbidity
Nephrology
Nephrology - Original Paper
NLR Family, Pyrin Domain-Containing 3 Protein - genetics
NLR Family, Pyrin Domain-Containing 3 Protein - metabolism
Phosphorylation
Rats
Sepsis
Tumor necrosis factor-α
Urology
title Overexpression of TRIM3 protects against LPS-induced acute kidney injury via repressing IRF3 pathway and NLRP3 inflammasome
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T07%3A04%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Overexpression%20of%20TRIM3%20protects%20against%20LPS-induced%20acute%20kidney%20injury%20via%20repressing%20IRF3%20pathway%20and%20NLRP3%20inflammasome&rft.jtitle=International%20urology%20and%20nephrology&rft.au=Li,%20Weiwei&rft.date=2022-06-01&rft.volume=54&rft.issue=6&rft.spage=1331&rft.epage=1342&rft.pages=1331-1342&rft.issn=1573-2584&rft.eissn=1573-2584&rft_id=info:doi/10.1007/s11255-021-03017-z&rft_dat=%3Cproquest_cross%3E2581815096%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2661274999&rft_id=info:pmid/34643859&rfr_iscdi=true